Literature DB >> 3553069

Nimodipine versus flunarizine in common migraine: a controlled pilot trial.

G Bussone, S Baldini, G D'Andrea, A Cananzi, F Frediani, L Caresia, F Ferro Milone, A Boiardi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3553069     DOI： 10.1111/j.1526-4610.1987.hed2702076.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  9 in total

Review 1.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

Review 2.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

3.  Nimodipine in migraine: clinical efficacy and endocrinological effects.

Authors:  R Formisano; P Falaschi; R Cerbo; A Proietti; T Catarci; R D'Urso; C Roberti; V Aloise; F Chiarotti; A Agnoli
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Migraine.

Authors:  J G Edmeads
Journal:  CMAJ       Date:  1988-01-15       Impact factor: 8.262

Review 5.  Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine.

Authors:  K E Andersson; E Vinge
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 6.  Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 7.  Nimodipine in otolaryngology: from past evidence to clinical perspectives.

Authors:  D Monzani; E Genovese; L A Pini; F Di Berardino; M Alicandri Ciufelli; G M Galeazzi; L Presutti
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-06       Impact factor: 2.124

Review 8.  Nimodipine Reappraised: An Old Drug With a Future.

Authors:  Andrew P Carlson; Daniel Hänggi; Robert L Macdonald; Claude W Shuttleworth
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 9.  Evidence-Based Treatments for Adults with Migraine.

Authors:  Rubesh Gooriah; Randa Nimeri; Fayyaz Ahmed
Journal:  Pain Res Treat       Date:  2015-12-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.